Highlights

Chula Pharmacy prepares to test “Baiya Vaccine” a Thai vaccine against COVID-19 by “Baiya Phytofarm”, a Chula startup. The vaccines have been produced at the first plant in Asia that manufactures plant-based vaccines for humans. Clinical trials with volunteers and the research for the second-generation vaccine to fight the virus variants are to commence in September 2021.

Because “death” is the end of every life, Chula is offering “Beautiful Death” – a new class on Chula MOOC to explore the meaning of life through a quality death.

Chula Faculty members joined forces in dental materials science to develop easy-to-use “light-activated dental materials” that meet international standards and help shorten tooth filling time. The secret of these innovative dental materials, made by Thai people, is Acemannan polymer from Aloe Vera that can stimulate the formation of dentin and reduce tooth sensitivity in many dental health products.

According to Chula researchers the volume of online gambling has soared during the COVID-19 pandemic, posing a serious threat to minors, and the government should urgently tackle this problem.

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.

Drinking too little water each day increases the risk of urinary stones. Recently, the Faculty of Medicine, Chulalongkorn University has successfully developed a concentrated beverage from blue pea flowers and banana stems to reduce the risk of urinary stones formation.

The COVID-19 situation may have restricted people’s space, but not their imagination. A Chula lecturer has given recommendations to parents who need to spend more time at home on select social activities to enhance children’s development in a safe and age-appropriate way.

The COVID-19 outbreaks in Thailand have seen an ever-increasing number of infections as new clusters are emerging. The faculty members of Sasin School of Management — Prof. Dr. Kua Wongboonsin, Asst. Prof. Dr. Piyachart Phiromswad, Assoc. Prof. Dr. Pattanaporn Chatjuthamard, Asst. Prof. Dr. Pattarake Sarajoti, and Asst. Prof. Dr. Sabin Srivannaboon, with financial support from the National Research Council of Thailand (NRCT), jointly present ways to reduce the spread of COVID-19 sustainably in a study to identify technologies that can instantly and appropriately help professionals who find social distancing difficult.

Thailand’s first Excellence Center for Sleep Disorders (Nidra Vej Center), King Chulalongkorn Memorial Hospital can solve sleep disorders that impair the quality of your life and health.

A Chula professor, in her local mushroom research, unveils “Thai Phellinus Mushroom (Phellinus linteus)” as having a destructive effect on cervical cancer cells. Additional research is currently being done to confirm its potency and low side effects, before making it available at an affordable price.

An Engineering professor, Chulalongkorn University has successfully converted carbon dioxide to methanol via a thermochemical method that consumes less energy and provides more yield, providing an alternative solution to reduce greenhouse gas emissions and stimulate the circular economy.

Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.

Chula researchers celebrate the success of Active Targeting, a revolutionary innovation in the medical industry using bio-robots to deliver targeted cordyceps extract to halt cancer with reduced side effects.

ViaBus, the first real-time public transport tracking and navigation application in Thailand is a groundbreaking work by Chula alumni who were among Forbes 30 under 30 Asia – 2021, a list honoring Asians under 30 years of age who dare to invest and develop innovations that will forever change the face of industries.

The King Chulalongkorn Memorial Hospital of the Thai Red Cross Society, together with the Faculty of Medicine, Chulalongkorn University now features a Gender Health Clinic, a safe space for LGBTQIA+ people to get advice about their health problems while cautioning that abuse of hormone therapy can be life-threatening.

Chulalongkorn University’s Faculty of Engineering and the Faculty of Arts have jointly developed the “Thai Speech Emotion Recognition Data Sets and Models”, now available for free downloads, to help enhance sales operations and service systems to better respond to customers’ needs.

SOPet, an online veterinary clinic and popular startup that gives instant advice on pet issues, is the brainchild of Chula sophomore students in the Bachelor of Arts and Science in Integrated Innovation (BAScii) degree, under CU Innovation Hub – a highlight of the strength of the social enterprise, fast, reliable, and affordable. Based on the life experience of pet owners who need urgent advice and assistance in times of crisis but are unable to rush to the clinic or veterinary hospital in time, SOPet was created.

“Cannabis” is a high-value cash crop with immense benefits in medicine, health, nutrition, and beauty. As soon as the Thai government had given the green light, Chulalongkorn was ready to join hands with the private sector and concerning government agencies to accelerate the research and development of a vast assortment of cannabis products.

Since the onset of the COVID-19 pandemic, the online food-ordering business has grown exponentially in parallel with the amount of plastic waste generated that has seen a 60% increase. The Environmental Research Institute, Chulalongkorn University (ERIC) points out that it is high time for all sectors to help reduce waste through the 3 Re Principles.

Queen Sirikit Center for Breast Cancer, King Chulalongkorn Memorial Hospital, Thai Red Cross Society (Chulalongkorn Hospital) has become the world’s first institution to have successfully used immunotherapy to treat a breast cancer patient who is now in complete remission with minimal side effects and uplifted quality of life.